Merck Joins Messenger RNA Frenzy, Betting $100M on Moderna Therapeutics


Generations of scientists have known that messenger RNA plays a key role in carrying genetic information in cells, but thought the molecules themselves could never be drugs. Merck, the pharmaceutical giant, just bet they can become drugs after all. Moderna Therapeutics, the Cambridge, Mass.-based company that has taken the biotech industry by [...]

view Forbes